Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0JV2S
|
|||
| Former ID |
DNC009705
|
|||
| Drug Name |
VU0119498
|
|||
| Synonyms |
1-(4-Bromobenzyl)indole-2,3-dione; VU0119498; 79183-37-2; 1-(4-bromobenzyl)-1H-indole-2,3-dione; CHEMBL523685; 1-[(4-bromophenyl)methyl]indole-2,3-dione; 1-[(4-bromophenyl)methyl]-2,3-dihydro-1H-indole-2,3-dione; STK215777; 1-(4-bromobenzyl)indoline-2,3-dione; AC1Q24VD; AC1MHO09; GTPL7632; SCHEMBL5430888; cid_3008304; MolPort-002-341-984; ZINC2454837; BDBM50258439; AKOS000245456; CCG-198352; NE20417; MCULE-6184534031; VU 0119498; ST50892639; VU-0119498; EU-0067620; VU0119498-2; 1-[(4-bromophenyl)methyl]indoline-2,3-dione
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H10BrNO2
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=O)C(=O)N2CC3=CC=C(C=C3)Br
|
|||
| InChI |
1S/C15H10BrNO2/c16-11-7-5-10(6-8-11)9-17-13-4-2-1-3-12(13)14(18)15(17)19/h1-8H,9H2
|
|||
| InChIKey |
DELLOEULSHGYCG-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
3720113, 7696867, 10038742, 12093808, 24360518, 26184285, 36057090, 57857327, 80556958, 81072527, 85285464, 89384916, 103613991, 104109119, 104793879, 111624248, 117387640, 124744854, 127116807, 131389383, 134346910, 143911986, 164326965, 170064040, 184024190, 223365967, 225159324, 231261309, 249355225
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Muscarinic acetylcholine receptor M5 (CHRM5) | Target Info | Inhibitor | [2] |
| KEGG Pathway | Calcium signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Cholinergic synapse | ||||
| Regulation of actin cytoskeleton | ||||
| Panther Pathway | Alzheimer disease-amyloid secretase pathway | |||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
| Reactome | Muscarinic acetylcholine receptors | |||
| G alpha (q) signalling events | ||||
| WikiPathways | Monoamine GPCRs | |||
| Calcium Regulation in the Cardiac Cell | ||||
| Regulation of Actin Cytoskeleton | ||||
| GPCRs, Class A Rhodopsin-like | ||||
| Gastrin-CREB signalling pathway via PKC and MAPK | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7632). | |||
| REF 2 | Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of ... J Med Chem. 2009 Jun 11;52(11):3445-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.